retatrutide clinical trial news Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS investigation Clinical Trials That Redefined Medicine

What Does GIP Do

And this one [berobenatide] is driving one of those two, whereas normally when you have a GLP-1 molecule, it drives both at the same time, he said

Your body still needs movement to stay resilient

Strategy Matters More Than the Drug: Both medications can lead to significant weight loss, but without a plan (strength training, nutrition, tapering off), users risk muscle loss, metabolic slowdown, and regaining weight later.

sygl-1(q828) , 11 1 (n = 49)

With two in-person clinic locations and secure telehealth appointments available statewide, we make professional weight management accessible wherever you live